Pocket Program - CROI

Poster Listings
Session 112 CROI 2013
c Tuesday, 2:30-4 pm; Hall B2
Session 112–Poster Abstracts
Detecting and Interpreting HIV Drug Resistance
597
HIV-1 Drug-resistance Mutations Associated with Pre-
Exposure Prophylaxis
Guoqing Zhang* 1 , H Guo1 , J DeVos1 , I Lorenzana de Rivera2 , I Zulu3 ,
N Wadonda-Kabondo4 , C Ndongmo3 , J Nkengasong1 , F Gao5 , and C Yang1 1 2 CDC, Atlanta, GA, US;; Natl Autonomous Univ of Honduras,
Tegucigalpa;; 3CDC-Zambia, Lusaka;; 4CDC-Malawi, Lilongwe;; and 5Duke Univ Med Ctr, Durham, NC, US
598
Interpretation in Europe
Charlotte Charpentier* 1 , R Camacho2 , J Ruelle3 , R Kaiser4 , J Eberle5 ,
A Pironti6 , M Stuermer7 , F Brun-Vezinet1 , D Descamps1 , and M Obermeier6 1 2 Hosp Bichat-Claude Bernard, Paris, France;; Univ Nova de Lisboa,
Portugal;; 3Univ Catholique de Louvain, Brussels, Belgium;; 4Univ of
Cologne, Germany;; 5Ludwig Maximilian Univ Munich, Germany;; 6Med Labor Dr Berg, Berlin, Germany;; and 7Johann Wolfgang Goethe-Univ
Hosp, Frankfurt, Germany
599 The Individualized Genetic Barrier Predicts Treatment
Response in a Large Cohort of HIV-1 + Patients
N Beerenwinkel 1 , H Knotzsch 1 , P Knupfer 1 , V von Wyl2 , S Yerly3 , J Boni4 ,
T Klimkait 5 , V Aubert 6 , Huldrych Gunthard* 2 , and Swiss HIV Cohort Study
1 2 3 ETH Zurich, Basel, Switzerland;; Univ Hosp Zurich, Switzerland;; Univ
Hosp Geneva, Switzerland;; 4Univ of Zurich, Switzerland;; 5Univ of Basel,
Switzerland;; and 6Ctr Hosp Univ Vaudois, Lausanne, Switzerland
600
st
Anne Derache* 1 , C Wallis2 , J Bartlett3 , E Aga4 , M Norton5 ,
K Klingman6 , W Stevens7 , D Katzenstein1 , and ACTG5230 Team
1 2 Stanford Univ, CA, US;; Lancet Labs, Johannesburg, South Africa;;
3 4 Duke Univ Med Ctr, Durham, NC, US;; Statistical Data Analysis Ctr
at Harvard Univ, Cambridge, MA, US;; 5Abbott Labs, Abbott Park,
IL, US;; 6DAIDS, NIAID, NIH, Bethesda, MD, US;; and 7Univ of the
Witswatersrand, Johannesburg, South Africa
601 Low-level HIV Viremia and Drug Resistance
Alejandro Gonzalez-Serna* 1 , JE Min1 , C Woods1 , J Li2 , R Harrigan1 ,
and L Swenson1 1 2 BC Ctr for Excellence in HIV/AIDS, Vancouver, Canada and Brigham
c Tuesday, 2:30-4 pm; Hall B2
Session 113–Poster Abstracts
Innovation in Measuring Viral Nucleic Acids
602
cleared Plasma HIV-1 RNA Assay Platforms for Determination
Christina Lalama* 1 , C Jennings2 , V Johnson3,4 , R Coombs5 , J McKinnon6 ,
J Bremer2 , B Cobb7 , G Cloherty8 , H Ribaudo1 , and J Mellors9 1 2 Harvard Sch of Publ Hlth, Boston, MA, US;; Rush Univ Med Ctr,
Chicago, IL, US;; 3Birmingham VAMC, AL, US;; 4Univ of Alabama at
Birmingham Sch of Med, US;; 5Univ of Washington, Seattle, US;; 6Henry Ford Hosp, Detroit, MI, US;; 7Roche Diagnostics, Pleasanton, CA, US;;
8 9 Abbott Molecular, Des Plaines, IL, US;; and Univ of Pittsburgh, PA, US
603
John McKinnon* 1 , C Lalama2 , S Riddler3 , R Haubrich4 , M Hughes2 ,
D Vagrattian3 , and J Mellors3 1 2 Henry Ford Hosp, Detroit, MI, US;; Harvard Sch of Publ Hlth, Boston,
MA, US;; 3Univ of Pittsburgh, PA, US;; and 4 606 Dried Blood Spots for HIV-1 Viral Load and Drug Resistance
Monitoring in HAART-treated Patients from Africa and
Asia: The Agence de Nationale de Recherche sur le Sida
Ahidjo Ayouba*
Univ of California, San
Diego, US
1 , M Monleau1 , S Eymard-Duvernay1 , A Dagnra2 ,
D Kania3 , N Ngo-Giang-Huong4 , C Toure-Kane5 , L Truong6 , M-L Chaix7 ,
A Aghokeng8 , and ANRS 12235 Study Group
1 2 IRD and Univ de Montpellier 1, France;; BIOLIM, FMMP/UL, Lome,
Togo;; 3Ctr Muraz, Bobo-Dioulasso, Burkina Faso;; 4Chiang Mai Univ,
Thailand;; 5Hosp Le Dantec, Dakar, Senegal;; 6Inst Pasteur, Ho Chi Minh
City, Vietnam;; 7Hosp Necker, Paris, France;; and 8CREMER/IMPM/IRD, Yaounde, Cameroon
607 Evaluation of Point-of-Care Nucleic Acid Testing for HIV
Viral Load and Early Infant Diagnosis in Primary Health
Ilesh Jani* 1 , B Meggi1 , A Vubil1 , N Sitoe1 , N Bhatt1 , O Tobaiwa2 ,
J Quevedo2 , O Loquiha3 , J Lehe2 , and T Peter2 1 2 Inst Nacional de Saude, Maputo, Mozambique;; Clinton Hlth Access
Initiative, Maputo, Mozambique;; and 3Univ Eduardo Mondlane, Maputo,
Mozambique
608
Carol Metcalf* 1 , E Fajardo1 , P Pannus2 , L Trevino3 , I Panunzi2 ,
T Ellman1 , R Coulborn2 , A Kamiza4 , R Mbewa5 , and P Chaillet6 1 2 Medecins Sans Frontieres, Cape Town, South Africa;; Medecins Sans
Frontieres, Thyolo, Malawi;; 3Medecins Sans Frontieres, Blantyre,
Malawi;; 4Malawi Ministry of Hlth, Thyolo;; 5Malawi Ministry of Hlth,
Lilongwe;; and 6Medecins Sans Frontieres, Brussels, Belgium
609
Eric Ramos*, M Chang, J Ortega, G Daza, E Goecker, S Harb,
J Dragavon, and R Coombs
Univ of Washington, Seattle, US
610 Real-time Polymerase Chain Reaction Evaluation of Seminal
HIV Viral Load
Roberto Rodriguez-Diaz* 1 , E Mendez-Hernandez1 , M Flores-Hernandez1 ,
E Mendoza-Guadarrama1 , L Rojo-Gutierrez2 , C Hernandez-Martinez1 ,
and L Soto-Ramirez1 1Inst Nacional de Ciencias Med y Nutricion Salvador Zubiran, Mexico
City, Mexico and 2Hosp Med Sur, Mexico City, Mexico
611
Korea
H Kim1 , NS Ku1 , SB Kim1 , SJ Jeong1 , SH Han1 , JM Kim1 , D Smith2 ,
and Jun Yong Choi* 1
1 2 AIDS Res Inst, Yonsei Univ Coll of Med, Seoul, Korea and Univ of
California, San Diego, La Jolla, US
612 Efficiency of HIV-1 Pooled Viral Load Testing to Reduce the
Cost of Monitoring ART in a Resource-limited Setting: Rural
Malawi
Pieter Pannus* 1 , E Fajardo1 , C Metcalf1 , L Trivino2 , D Garone2 ,
R Coulborn2 , H Bygrave1 , T Ellman1 , M Murowa3 , and R Mwenda4 1Medecins Sans Frontieres, South African Med Unit, Cape Town, South
Africa;; 2Medecins Sans Frontieres, Thyolo, Malawi;; 3Ministry of Hlth,
District Mgmt Office, Thyolo, Malawi;; and 4Ministry of Hlth, DDTSS,
Lilongwe, Malawi
613
Testing in Resource-limited Settings
Emily Hyle* 1 , I Jani2 , J Lehe3 , R Wood4 , A Su1 , J Quevedo3 , E Losina1,5,6 ,
I Bassett1,5 , T Peter3 , and R Walensky1,5,6 1 2 Med Practice Evaluation Ctr, Massachusetts Gen Hosp, Boston, US;; Inst
Nacional da Saude, Maputo, Mozambique;; 3Clinton Hlth Access Initiative,
Maputo, Mozambique;; 4Desmond Tutu HIV Fndn, Univ of Cape Town,
South Africa;; 5Ctr for AIDS Res, Harvard Med Sch, Boston, MA, US;;
and 6 604 Refining Approaches to Viral Load Monitoring Using Dried
Blood Spots
Carole Wallis* 1 , E Aga 2 , H Ribaudo 2 , C Chevallier 3 , K Klingman 4 ,
W Stevens 5 , N Kumarasamy 6 , J Bartlett 7 , D Katzenstein 8 , and A5230 Team
1 Lancet Labs, Johannesburg, South Africa;; 2 Statistical Data Analysis
Ctr, Harvard Sch of Publ Hlth, Boston, MA, US;; 3 Clinton Hlth Access
Initiative, Papua New Guinea;; 4 NIAID, NIH, Bethesda, MD, US;; 5 Univ of
the Witwatersrand, Johannesburg, South Africa;; 6 YRG Care, Voluntary
Hlth Svcs, Chennai, India;; 7 Duke Univ Med Ctr, Durham, NC, US;; and
8 Stanford Univ, CA, US
605 Assessment of Treatment Efficacy with Virological and
Pharmacological Evaluations on Capillary Dried Blood Spots
in HIV + Patients Enrolled in a West African Cohort
M Daou 1,2 , M Le 3 , B Madougou 1,2 , C Delaugerre 4 , T Maillard 4 , G Peytavin 3 ,
E Adehossi 1 , M Saidou 1 , E Rouveix 2,5 , and Pierre de Truchis* 2,5
1 Hosp Natl, Niamey, Niger;; 2 Gip-ESTHER Niger, France;; 3 Hosp Bichat
Claude Bernard APHP, Paris, France;; 4 Hosp St Louis, APHP, Paris,
France;; and 5 GH A Pare-R Poincare, Garches, France
44 20th Conference on Retroviruses and Opportunistic Infections
c Tuesday, 2:30-4 pm; Hall B2
Session 114–Poster Abstracts
Transmitted Drug Resistance
614 Origin of Minority Drug-resistant HIV-1 Variants in Primary
HIV-1 Infection
Karin Metzner*, A Scherrer, B Preiswerk, B Joos, V von Wyl, C Leemann,
D Braun, C Grube, H Kuster, H Gunthard, and Swiss HIV Cohort Study
Univ Hosp Zurich, Univ of Zurich, Switzerland
615 Trends in Genotypic Resistance Testing Use and Results
among ARV-naïve Patients in the HIV Outpatient Study
Kate Buchacz* 1 , B Young 2,3 , F Palella 4 , C Armon 5 , J Brooks 1 ,
and HIV Outpatient Study Investigators
1 CDC, Atlanta, GA, US;; 2 Apex Family Med and Res, Denver, CO,
US;; 3 Intl Assn of Physicians in AIDS Care, Washington, DC, US;;
4 Northwestern Univ Sch of Med, Chicago, IL, US;; and 5 Cerner Corp,
Vienna, VA, US